-
Portrait | 2022.03.29
Jean-Claude Manuguerra: viruses, animals and humans
It all started with a veterinarian and a cross-eyed lionJean-Claude Manuguerra was 7 when he decided that he wanted to become a veterinarian, to "save animals" – like in the TV series Daktari, which he was an avid fan of at the time. In the series, Dr. Marsh Tracy was a vet who cared for local animals and ran the Wameru Study Center for Animal Behavior in Kenya. Marsh Tracy was aided in his day-...
-
Document de presse | 2022.07.13
Light shed on SARS-CoV-2 replication in bat cells
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
-
News | 2023.09.19
HIV-AIDS : inspiring patients
With early and rigorous treatment, some so-called "controller" patients are able to keep their viral load low enough to not suffer from AIDS. These are inspiring cases for research, not to mention the very rare patients who have already been completely cured of HIV.
-
Document de presse | 2024.03.28
Inauguration in Brazil of the Institut Pasteur de São Paulo, member of the Pasteur Network
On March 27, 2024, the Institut Pasteur de São Paulo was inaugurated by French President, Emmanuel Macron. As a member of the Pasteur Network, this institute, founded by the Institut Pasteur and the University of São Paulo, conducts international-level research in the field of health biology to further understanding of diseases and their impact on human health, especially in the context of...
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
Document de presse | 2024.11.21
Phages, towards a targeted alternative to antibiotics
With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...
-
News | 2022.12.27
Bicentenary of Louis Pasteur's birth: looking back on a year of commemorations
Two hundred years ago, on December 27, 1822, Louis Pasteur was born in the town of Dole, in the Jura region of France. The year 2022 was an opportunity to celebrate Louis Pasteur's scientific and cultural legacy and to give people a chance to discover – or rediscover – his life and work.
-
News | 2025.03.08
A collective effort for the Wikipedia pages of women scientists
On February 7, 2025, the Institut Pasteur and the les sans pagEs association organized their very first Editathon – a collaborative workshop on the Wikipedia encyclopedia – dedicated to women scientists. The aim of this event was to bring the contribution of scientists out of the shadows by creating and expanding Wikipedia pages. A fine collective effort with tangible...
-
Document de presse | 2020.03.19
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh.CEPI to provide initial US$4.9 million for consortium to develop a Covid-19 vaccine candidate based on measles-vector technology.Partnership becomes eighth Covid-19 vaccine development project that CEPI has signed since Jan 23, 2020 OSLO, NORWAY, March 19, 2020 – CEPI, the Coalition for...
-
News | 2020.11.26
Presbycusis: ultra-rare genetic mutations responsible for a quarter of cases occurring around the age of 50
Presbycusis, or age-related hearing loss, involves genetic and environmental factors. A genomic analysis can identify gene variants whose pathogenicity subsequently needs to be confirmed. As a general rule, frequent variants have little or very little effect; it is their cumulative impact in several genes that explains the impairment. Ultra-rare variants, on the other hand, have a strong impact...